These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32703610)

  • 41. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
    Anusha C; Sumathi T; Joseph LD
    Chem Biol Interact; 2017 May; 269():67-79. PubMed ID: 28389404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis.
    Pesant M; Sueur S; Dutartre P; Tallandier M; Grimaldi PA; Rochette L; Connat JL
    Cardiovasc Res; 2006 Feb; 69(2):440-9. PubMed ID: 16337160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective Effect of Unsaturated Fatty Acids on Palmitic Acid-Induced Toxicity in Skeletal Muscle Cells is not Mediated by PPARδ Activation.
    Tumova J; Malisova L; Andel M; Trnka J
    Lipids; 2015 Oct; 50(10):955-64. PubMed ID: 26255030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sirtuin 1 Mediates the Actions of Peroxisome Proliferator-Activated Receptor δ on the Oxidized Low-Density Lipoprotein-Triggered Migration and Proliferation of Vascular Smooth Muscle Cells.
    Hwang JS; Ham SA; Yoo T; Lee WJ; Paek KS; Lee CH; Seo HG
    Mol Pharmacol; 2016 Nov; 90(5):522-529. PubMed ID: 27573670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells.
    Ding J; Gou Q; Jin J; Shi J; Liu Q; Hou Y
    Eur J Pharmacol; 2019 Aug; 857():172425. PubMed ID: 31150647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ligand-activated PPARδ inhibits UVB-induced senescence of human keratinocytes via PTEN-mediated inhibition of superoxide production.
    Ham SA; Hwang JS; Yoo T; Lee H; Kang ES; Park C; Oh JW; Lee HT; Min G; Kim JH; Seo HG
    Biochem J; 2012 May; 444(1):27-38. PubMed ID: 22335598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PPARδ agonist enhances colitis-associated colorectal cancer.
    Zhou D; Jin J; Liu Q; Shi J; Hou Y
    Eur J Pharmacol; 2019 Jan; 842():248-254. PubMed ID: 30391747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
    Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1141-1150. PubMed ID: 31408200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth.
    Xu L; Han C; Wu T
    J Biol Chem; 2006 Nov; 281(45):33982-96. PubMed ID: 16966336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand-activated PPARδ modulates the migration and invasion of melanoma cells by regulating Snail expression.
    Ham SA; Yoo T; Hwang JS; Kang ES; Lee WJ; Paek KS; Park C; Kim JH; Do JT; Lim DS; Seo HG
    Am J Cancer Res; 2014; 4(6):674-82. PubMed ID: 25520859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and evaluation of erucic acid-phytosphingosine structured cationic nanoemulsions as a plasmid DNA delivery system against breast cancer cells.
    İsar S; Akbaba H; Şahİn Y; Altinöz MA; Nalbantsoy A; Erel-Akbaba G; Başpınar Y
    Pharm Dev Technol; 2022 Feb; 27(2):145-154. PubMed ID: 35021932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.
    Zizola C; Kennel PJ; Akashi H; Ji R; Castillero E; George I; Homma S; Schulze PC
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1078-85. PubMed ID: 25713305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.
    Sadeghian M; Marinova-Mutafchieva L; Broom L; Davis JB; Virley D; Medhurst AD; Dexter DT
    J Neuroimmunol; 2012 May; 246(1-2):69-77. PubMed ID: 22498097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516.
    Lagu B; Kluge AF; Goddeeris MM; Tozzo E; Fredenburg RA; Chellur S; Senaiar RS; Jaleel M; Babu DRK; Tiwari NK; Takahashi T; Patane MA
    Bioorg Med Chem Lett; 2018 Feb; 28(3):533-536. PubMed ID: 29275935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson's disease.
    Gaballah HH; Zakaria SS; Elbatsh MM; Tahoon NM
    Chem Biol Interact; 2016 May; 251():10-6. PubMed ID: 27016191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL; Lin JJ; Goldfine ID
    Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of peroxisome proliferator-activated receptor delta suppresses BACE1 expression by up-regulating SOCS1 in a JAK2/STAT1-dependent manner.
    Lee WJ; Ham SA; Lee GH; Choi MJ; Yoo H; Paek KS; Lim DS; Hong K; Hwang JS; Seo HG
    J Neurochem; 2019 Nov; 151(3):370-385. PubMed ID: 31063584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.